Asana Inc. buy BiotechBee
Start price
01.10.23
/
50%
€17.55
Target price
31.10.25
€20.00
Performance (%)
20.60%
End price
02.12.23
€21.17
Summary
This prediction ended on 02.12.23 with a price of €21.17. The prediction had a final performance of 20.60%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Asana Inc. | -4.754% | -4.754% | -36.017% |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% |
According to BiotechBee what are the pros and cons of Asana Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Asana Inc. diskutieren
Buy mit Kursziel 20,0
In the thread Trading Asana Inc.
Buy beendet

